Skip to Content

JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

There is no panel matching the key "Alert---Site-Wide"

Clinical Trials Search Results

Search for

in

Accepting Participants (3)

Showing 1-3 of 3

Sorted By:

A-Z
Z-A

Previous Next

A091903: A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal Melanoma
A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal Melanoma
IMA203-301_SUPRAME (IMA203): A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)
Ph3 study of treatment w/IMA203 administered at the recommended ph2 dose vs MD choice in pts w/previously treated, unresectable or metastatic cutaneous melanoma.
IOV-EAP-402: Expanded Access Program of AMTAGVI that is Out of Specification for Commercial Release
The objective of this expanded access protocol is to provide access to Out Of Specification (OOS) AMTAGVI treatment to patients

Previous Next